Camlin Fine Sciences Limited has informed the Exchange about Opening of Judicial Liquidation Proceedings of CFS Europe S.p.A., a wholly owned subsidiary of the Company.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts less than Nifty Microcap 250 and 6.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Camlin Fine Sciences has informed the exchanges that the Ordinary Court of Ravenna, Italy has ordered the opening of judicial liquidation proceedings against its wholly owned subsidiary, CFS Europe S.p.A. The proceedings are being conducted under the Italian Code of Corporate Crisis and Insolvency, following an appeal filed by the subsidiary's Board of Statutory Auditors in January 2026. A delegated Judge and Court-appointed Liquidators (Curatori) have been appointed to manage the process. As of March 31, 2025, the Italian subsidiary contributed 4.72% (₹7,873.81 Lakhs) of consolidated turnover and 9.73% (₹8,512.36 Lakhs) of net worth. The company has stated further updates will be provided as material developments occur.
This is a negative development for shareholders, as it confirms the loss of a foreign subsidiary and indicates financial distress within part of the group's international operations. While the subsidiary's contribution to turnover is modest (~5%), its 9.73% contribution to net worth means shareholders could see a meaningful write-down. Expect short-term pressure on the stock given the loss of value from this subsidiary, though the impact on overall group operations may be limited.